KAHR Medical

KAHR MedicalKAHR Medical
KAHR Medical

KAHR Medical

Developing immunotherapeutic bi-functional fusion proteins to harness the immune system against cancer.

DR 3.92011Active50Jerusalem, Israel
Rate

About

KAHR Medical is a biopharmaceutical company focused on developing a novel drug platform of immunotherapeutic bi-functional fusion proteins. These innovative therapies are designed to leverage the human immune system to target multiple cancer indications, offering a new approach to cancer treatment.
Frequently asked

What does KAHR Medical do?

KAHR Medical is a biopharmaceutical company focused on developing a novel drug platform of immunotherapeutic bi-functional fusion proteins. These innovative therapies are designed to leverage the human immune system to target multiple cancer indications, offering a new approach to cancer treatment.

What is KAHR Medical's revenue?

StartupHub estimates KAHR Medical's annual revenue at $9.2M (range $6.5M to $23.1M, 68% confidence), based on comparable companies in the sector.

Where is KAHR Medical headquartered?

KAHR Medical is headquartered in Jerusalem, Israel.

When was KAHR Medical founded?

KAHR Medical was founded in 2011.

What industry does KAHR Medical operate in?

KAHR Medical operates in Healthcare, Biotech, MedTech, HealthTech, Drug Discovery, Immunotherapy.

How many employees does KAHR Medical have?

KAHR Medical has approximately 50 people on record.

HEADCOUNT
50
DOMAIN RATING
3.9
Comments

No comments yet. Be the first to share your take.